`
`Joint Status Report Pursuant to Rule 26(f)
`
`Caption:
` Civil Action No:
`Basis of Jurisdiction:
`Arbitration:
`Jury Trial:
`Non-Jury Trial:
`Plaintiff’s counsel participating in the Rule 16 Conference:
`Brian Egan, James Hurst, Patricia Carson, Mark McLennan
`Defendant’s counsel participating in the Rule 16 Conference:
`Do counsel have full authority to settle at Rule 16 Conference?
`If not, client with such authority who will attend conference:
`When did the parties hold the Rule 26 Conference?
`When did the parties comply with Rule 26(a)’s duty of self-executing disclosure?
`Does either side expect to file a case-dispositive motion?
` (yes/no)
`If yes, under what Rule
`If yes, specify the issue
`Proposed deadline for filing dispositive motions:
`Does either side anticipate the use of experts?
`
`If yes, what is the proposed deadline for expert discovery?
`Approximate date case should be trial-ready:
`Time for Plaintiff’s case:
`Time for Defendant’s case:
`Is a settlement conference likely to be helpful?
`If so, when:
`Early (yes/no)
`After Discovery
` (yes/no)
`What is the outcome of your discussions with your clients about proceeding before a
`Magistrate Judge for final disposition?
`
`
`
`
`
`
`
`22-252
`
`28 U.S.C. §§ 1331, 1338(a)
`
`See Proposed Scheduling Order ¶ 14
`
`Yes
`
`N/A
`
`December 20, 2022
`
`See Proposed Scheduling Order ¶ 14
`
`See Proposed Scheduling Order ¶ 14
`
`Yes
`
`See Proposed Scheduling Order ¶ 19, Ex. A
`
`Magistrate Judge for final disposition.
`
`The parties do not consent to proceeding before a
`
`No
`
`N/A
`
`N/A
`
`Arbutus Biopharma Corporation and Genevant Sciences GmbH v. Moderna, Inc. and ModernaTX, Inc.
`
`See Proposed
`Scheduling Order ¶ 1
`
`See Proposed
`Scheduling Order ¶ 14
`
`See Proposed Scheduling
`Order ¶ 7(f), Ex. A
`
`See Proposed Scheduling
`Order ¶ 19, Ex. A
`
`See Proposed Scheduling
`Order ¶ 19, Ex. A
`
`Karen Keller, Daralyn J. Durie, David I. Berl, Shaun P. Mahaffy
`
`
`
`Case 1:22-cv-00252-MSG Document 47 Filed 02/13/23 Page 2 of 2 PageID #: 881
`
`Plan for Discovery:
`
`1.
`
`The parties anticipate that discovery should be completed within
`days.
`
`
`2.
`
`
`3.
`
`
`4.
`
`
`5.
`
`
`
`
`
`
`
`
`
`
`
`
`What is the minimum amount of time necessary to complete discovery prior to an
`ADR session, should one be ordered or agreed to?
`
`Have the parties discussed issues relating to claims of privilege or of protection as
`trial-preparation material, as required by Rule 26(f)(3)(D)?
`
`Identify any other discovery issues which should be addressed at the Rule 16
`Conference, including limitations on discovery, protective Orders needed, or other
`elements which should be included in a particularized discovery plan.
`
`
`If you contend the discovery period should exceed 90 days, please state reason:
`
`
`This form should be faxed to Chambers at 267-299-5056 or
`Emailed to chambers at goldberg_chambers@paed.uscourts.gov
`
`
`433 to 554
`
`433 to 554 days.
`
`Yes
`
`The scope of document production, number of witnesses, and expert discovery necessitate a discovery period of more than 90 days.
`
`The parties have disputes
`
`regarding final contentions, expert supplementation, trial length, and the case schedule.
`
`